mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.26 |
2e-06 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-06 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |